Disclaimer: this research study’s copyright belongs to the authors and PubMed and not HealthMatReview.com, further details below.
Our Summary
Low-frequency PEMF has shown to be effective in treating osteoporosis but the exact process has yet to be verified. With this, the project aims to test the effectivity of PEMF exerts on intracellular reactive oxygen species (ROS) production and receptor activator of nuclear factor-?B ligand (RANKL)-induced osteoclast genesis. Cells were exposed to PEMF with 75 Hz frequency and 1 mT intensity. Results showed the inhibitory effect of PEMF on RANKL-induced osteoclastic differentiation and decreased intracellular ROS generation during osteoclastic differentiation. This may serve as the groundwork for future osteoclast-associated bone disease treatment using PEMF.
Pubmed Study Link
PDF Study Link
Study Categories
Authors
[‘Ying Pi’, ‘Haifeng Liang’, ‘Qiang Yu’, ‘Yukun Yin’, ‘Haixia Xu’, ‘Yutian Lei’, ‘Zhongyu Han’, ‘Jing Tian’]
PMID
30942408
PMCID
PMC6470919
Published Date

more study details
Frequency (Hz)
Frequency Range
Intensity (G)
Intensity Range
Waveform
PEMF/EMF/RF/LT
Study Subject Types
Keywords Listed
pulsed electromagnetic field, osteoclast, differentiation, reactive oxygen species, receptor activator of nuclear factor-?B signaling
Added Descriptive Keywords
brittle bone, spine, broken bone, back pain, osteoporosis, human
Disclaimer
All intellectual property and copyright of this research study sourced from PubMed, is the property of the authors and associates and is not the property of HealthMatReview.com. This research study has been included in our custom PEMF research database for the educational purposes of our readers. The on page summary, added descriptive keywords and other study details are copyright of HealthMatReview.com and were added to improve the search function of this custom research database.


Comments are moderated. Tick “Email me when my question is replied to” to get notified.